Adoption of robot-assisted radical nephroureterectomy permits a minimally invasive option for management of upper tract urothelial carcinoma in geriatric patients: comparison with non-geriatric patients with intermediate-term oncologic follow-up

To assess the oncologic efficacy and safety of robot-assisted approach to radical nephroureterectomy (RARNU) in geriatric versus younger patients with upper tract urothelial carcinoma (UTUC). A single-center, retrospective cohort study was conducted from 2009 to 2022 of 145 patients (two cohorts: 

Saved in:
Bibliographic Details
Published in:Journal of robotic surgery 2024-06, Vol.18 (1), p.257, Article 257
Main Authors: Refugia, Justin M., Thakker, Parth U., O’Rourke, Timothy K., Cohen, Adam, Bradshaw, Aaron, Casals, Randy, Sandberg, Maxwell, Whitman, Wyatt, Saini, Sumit, Hemal, Ashok K.
Format: Article
Language:English
Subjects:
Age
Age Factors
Aged
Aged, 80 and over
Biopsy
Bladder
Bladder cancer
Blood transfusions
Cancer therapies
Carcinoma, Transitional Cell - mortality
Carcinoma, Transitional Cell - surgery
Chemotherapy
Estimates
Female
Follow-Up Studies
Hospitals
Humans
Kidney Neoplasms - pathology
Kidney Neoplasms - surgery
Laparoscopy
Male
Medical prognosis
Medicine
Medicine & Public Health
Metastasis
Middle Aged
Minimally Invasive Surgery
Minimally Invasive Surgical Procedures - methods
Mortality
Neoplasm Recurrence, Local - epidemiology
Nephroureterectomy - methods
Pathology
Patients
Retrospective Studies
Robotic Surgical Procedures - adverse effects
Robotic Surgical Procedures - methods
Robots
Surgery
Surveillance
Survival
Treatment Outcome
Urogenital system
Urologic Neoplasms - mortality
Urologic Neoplasms - surgery
Urology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To assess the oncologic efficacy and safety of robot-assisted approach to radical nephroureterectomy (RARNU) in geriatric versus younger patients with upper tract urothelial carcinoma (UTUC). A single-center, retrospective cohort study was conducted from 2009 to 2022 of 145 patients (two cohorts: 
ISSN:1863-2491
1863-2483
1863-2491
DOI:10.1007/s11701-024-02013-6